Loading
Fluicell AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest was filed 09 Mar 2026.
Fluicell AB: what insiders have been doing
Fluicell AB belongs to the Health Care sector. Filings by its managers are published through Finansinspektionen. From 18 October 2025 to 18 October 2026, the disclosure feed for Fluicell AB logged 2 filings by 1 insider.
Only purchases show up on the open market, 2 purchases in all worth €1,557, filed by 1 insider. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 1 finance chief. One trade stands out by size: a purchase of €942 from Joakim Wahlberg, disclosed on 16 December 2025, or 0.024% of market capitalisation.
The last insider purchase was made public on 9 March 2026, 223 days ago.
Across the 890 companies tracked on its exchange, the median is 7 filings; at 2 filings, this issuer sits below that mark. Our records for Fluicell AB go back to 2021, with 5 purchases and no sales on the open market in total.
Elsewhere in the same sector, our signals recently picked up insider purchases at Anixa Biosciences Inc and Vivos Inc. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Insider Decl.
5
Thresholds
n/a
Buy Volume
€31,947
5 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleJoakim Wahlberg2 buys
Financial data
as of FY 2025FY ended December 2025 · cache
SEK 28.50
Analyst consensus
Income statement
RevenueSEK 6M
Gross profitSEK 13.1M219% margin
EBITDA-SEK 7.9M-131% margin
Net income-SEK 8.3M15.2% margin
Valuation
PER (trailing)14.0x
P/Book2.4x
Beta2.12
Balance sheet & cash
Market capSEK 39.2M
Free Cash Flow-SEK 13.6M
Debt / Equity12%
Profitability & ownership
ROE18.6%
ROA7.4%
% insiders21.2%
% institutions8.9%
Last declaration on 9 March 2026
Declarations5 total
600 shares@ SEK 11.000.016% mcap39.5% of flowAktieISIN SE0023595459FI:A003W850-1
Canonical exit: 4 Jun 2026 (T+90)
1,000 shares@ SEK 10.300.024% mcap60.5% of flowAktieISIN SE0023595459FI:A003U715-1
Canonical exit: 9 Mar 2026 (T+90)
3,800 shares@ SEK 28.20100.0% of flowAktieISIN SE0010831321FI:A001P445-1
Canonical exit: 11 Apr 2021 (T+90)
3,500 shares@ SEK 28.643100.0% of flowAktieISIN SE0010831321FI:A001P449-1
Canonical exit: 11 Apr 2021 (T+90)
5 of 5 declarations
About Fluicell AB
Fluicell AB is a company focused on developing technologies for biomedical research. It offers innovative solutions for cellular analysis and tissue biology.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
